Biostamp nPoint Device

DEVICE2 trials

Sponsors

University of Rochester, Northwestern University

Conditions

ChoreaHuntington DiseasePrenatal Stress

Phase 2

Risperidone for the Treatment of Huntington's Disease Involuntary Movements

CompletedNCT04201834

University of RochesterChorea, Huntington Disease

Start: 2020-08-13End: 2023-12-30Updated: 2025-03-21

Unknown Phase

Promoting Healthy Brain Development: Wellness for 2 Study

CompletedNCT05052281

Northwestern UniversityPrenatal Stress

Start: 2019-07-15End: 2024-07-31Updated: 2025-02-19

Related Papers

Effects of a Personalized Stress Management Intervention on Maternal Mental Health: A Randomized Clinical Trial

Archives of Women s Mental Health2025-09-171 citations